Clenbuterol 0,: Compound Profile
Clenbuterol 0.02mg LA Pharma is a selective β2-adrenergic receptor agonist extensively studied for its metabolic and thermogenic properties in laboratory settings. This pharmaceutical-grade compound enables researchers to investigate cellular mechanisms of lipolysis, thermogenesis, and metabolic rate modulation. Scientists at Stroid UK Shop commonly examine this compound’s effects on adipose tissue metabolism and its interaction with sympathetic nervous system pathways. The precise 0.02mg formulation allows for accurate dosimetric studies in controlled research environments, making it valuable for investigating β-adrenergic signalling cascades and their physiological implications.
Laboratory Applications
Research applications focus on studying clenbuterol’s mechanism of action through β2-adrenoceptor binding and subsequent cyclic adenosine monophosphate (cAMP) elevation. Investigators examine its thermogenic effects by analysing uncoupling protein expression in brown adipose tissue samples. Comparative studies often evaluate this compound alongside other research materials from our clenbuterol collection to understand structure-activity relationships. Researchers investigate its potential interactions with other metabolic modulators, including compounds from our SARMs and peptides categories, to explore synergistic metabolic pathways in cellular models.
Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Clenbuterol Hydrochloride |
| Concentration | 0.02mg per unit |
| Manufacturer | LA Pharma |
| Form | Pharmaceutical tablet |
| CAS Number | 21898-19-1 |
| Molecular Formula | C12H18Cl2N2O |
| Molecular Weight | 277.19 g/mol |
| Storage | Room temperature, dry conditions |
Research Compliance
This product is manufactured exclusively for in-vitro research and laboratory analysis. Clenbuterol 0.02mg LA Pharma is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper licensing and institutional approval before conducting studies. All investigations should follow established protocols for handling pharmaceutical compounds and comply with relevant research regulations and safety guidelines.
